글로벌 경피 패치 시장 – 2031년까지의 산업 동향 및 예측

경피 패치 시장 분석 및 규모

의료 분야의 경피 패치 시장에서 이러한 패치는 경피 투여 개념을 활용하여 약물 전달에 대한 혁신적인 접근 방식을 도입합니다. 피부에 부착되어 약물을 혈류로 직접 제어 방출하여 지속적인 완화와 최소화된 부작용을 제공합니다. 통증 관리, 호르몬 대체 요법 및 니코틴 대체 요법 에 널리 사용되는 경피 패치는 기존 경구 약물에 대한 신중하고 편리한 대안을 제공합니다. 그 효능은 멀미 예방, 신경 장애 관리 및 다양한 치료적 요구 사항 해결로 확장되어 경피 의료 치료에서 상당한 진전을 나타냅니다.

글로벌 경피 패치 시장 규모는 2023년에 74억 8천만 달러로 평가되었으며, 2031년까지 109억 7천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 4.9%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

경피 패치는 피부에 붙이는 접착 패치로, 시간이 지남에 따라 피부를 통해 혈류로 약물을 전달합니다. 소화계를 우회하여 약물을 투여하는 편리하고 통제된 방법을 제공하며 지속적인 치료 효과를 위해 지속적으로 방출합니다.

경피 패치 시장 동향

운전자                                                                                          

• 흡연 인구 증가로 인해 경피 패치에 대한 수요 증가

The region's growing smoking population, as evidenced by the CDC's data indicating high usage rates among both high school and middle school students, underscores the escalating demand for smoking cessation aids like nicotine transdermal patches. With approximately 34.0% of high school students and 11.3% of middle school students having used tobacco products, including cigarettes, e-cigarettes, and other variants, there's a pressing need for effective strategies to combat nicotine addiction. Transdermal patches offer a viable solution, providing a discreet and gradual method for delivering nicotine replacement therapy. This surge in demand fueled by the youth demographic contributes significantly to the expansion of the transdermal patches market in the region.

• Increased Prevalence of Cancer Propels the Adoption of Transdermal Patches

The escalating incidence of breast and prostate cancer, as highlighted by reports like GLOBOCAN 2020, notably accelerates the growth trajectory of the transdermal patches market. With Mexico alone projecting a substantial increase in cancer cases over the coming decades, reaching 254,665 new cases by 2030 and 323,432 by 2040, and the demand for innovative drug delivery systems intensifies. Transdermal patches, particularly those containing medication nanoparticles tailored for cancer therapy-related pain management, stand poised to address this growing need. Their non-invasive nature and ability to provide controlled release make them an attractive option for patients grappling with pain associated with cancer treatments, further solidifying their role as a vital component in oncology care, specifically in the domain of transdermal patches for pain.

Opportunities

• Technological Advancements Propel Transdermal Patches to New Levels of Versatility

Innovations in patch design, materials, and drug delivery mechanisms continually enhance the efficacy, safety, and versatility of transdermal patches. These advancements enable the delivery of a broader range of drugs, including those with challenging physicochemical properties, expanding the market's scope across various therapeutic areas. Advancements in manufacturing processes improve scalability and reduce production costs, making transdermal patches more accessible to patients and healthcare providers. As technology evolves, it drives the development of novel patch-based delivery systems, stimulating market expansion and fostering a competitive landscape driven by innovation.

• Rising Healthcare Facility Investments lead to the Adoption of Transdermal Patches

With greater investment, healthcare facilities can afford to adopt and promote innovative drug delivery systems like transdermal patches. These investments enable facilities to enhance their infrastructure, procure advanced medical technologies, and expand their range of treatment options. As healthcare providers strive to improve patient care and outcomes, they increasingly embrace transdermal patches for their convenience and efficacy through improved medication adherence and management of chronic conditions. This growing investment creates a conducive environment for the widespread adoption and utilization of transdermal patches in various healthcare settings, thereby driving market expansion.

Restraints/Challenges

• High Product Cost Limits the Adoption of Transdermal Patches

Compared to conventional oral medications, transdermal patches often entail higher manufacturing expenses due to specialized formulation requirements and the need for precise drug delivery systems. The production of patches with advanced features, such as controlled-release mechanisms, can further increase production costs. These higher manufacturing costs may translate into elevated prices for consumers, potentially limiting their affordability and accessibility, particularly in healthcare systems with budget constraints. Consequently, addressing cost concerns is crucial for ensuring widespread adoption and equitable access to transdermal patches as a viable drug delivery option.

• Skin Irritation Affecting Patient Comfort Limits Transdermal Delivery Systems

Adhesive components or drug formulations in patches may trigger allergic reactions or irritate sensitive skin, limiting their use in specific individuals. This issue necessitates careful consideration of patch materials and formulations to minimize adverse skin reactions. Moreover, skin irritation can lead to discontinuation of treatment and loss of patient confidence in transdermal delivery systems.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Adlarity, developed by Corium, debuted in the U.S. as a prescription medication. This once-weekly transdermal patch delivers consistent doses of donepezil, offering a convenient treatment option for patients with mild, moderate, or severe Alzheimer’s-related dementia. Its innovative delivery system aims to enhance patient compliance and improve therapeutic outcomes
• In 2022, the Luye Pharma Group received approval from China's National Medical Products Administration for their Rivastigmine Twice Weekly Transdermal Patch. This patch, designed for mild to moderate Alzheimer's symptoms, offers a convenient dosing schedule and aims to improve patient adherence. With its innovative transdermal delivery method, it represents a promising addition to Alzheimer's disease management in China

Transdermal Patches Market Scope

The market is segmented on the basis of product, type, application, technology, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Single-Layer Drug-In-Adhesive
• Multi-Layer Drug-In-Adhesive
• Matrix
• Reservoir
• Vapor
• Others

Type

• Fentanyl Transdermal Patch
• Nicotine Transdermal Patch
• Buprenorphine Transdermal Patch
• Clonidine Transdermal Patch
• Oxybutynin Transdermal Patch
• Others

Application

• Cardiovascular Disorder
• Central Nervous System Disorders (CNS)
• Pain Management/ Relief
• Smoking Reduction and Cessation Aid
• Overactive Bladder
• Nicotine Cessation
• Hormonal Therapy/ Disorders
• Dermatology
• Others

Technology

• Electric Current
• Mechanical Arrays
• Thermal Ablation
• Chemical Enhancers
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

End User

• Home Care settings
• Hospitals
• Clinics

Transdermal Patches Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product, type, application, technology, distribution channel, and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America is expected to dominate the market due to the region boasts a robust network of healthcare facilities, facilitating widespread access to treatment. Major players in the pharmaceutical industry have established a significant presence in North America, driving innovation and distribution. Additionally, the region's commitment to research and development in healthcare fuels continuous advancements, further solidifying its dominance in the market. These factors collectively contribute to North America's stronghold in the pharmaceutical landscape.

Asia-Pacific is expected to have substantial growth, driven by various factors. Government initiatives promoting healthcare awareness, coupled with expanding healthcare infrastructure, will catalyze this growth. Increased research activities further contribute to reaching the region's vast undiscovered markets and large population base. Moreover, the rising demand for quality healthcare services underscores the region's potential as a critical player in the global healthcare landscape.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Transdermal Patches Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• AdhexPharma (France)
• ProSolus, Inc (U.S.)
• tesa SE (Germany)
• Nitto Denko Corporation. (Japan)
• Noven Pharmaceuticals, Inc (U.S.)
• LTS Lohmann Therapie-Systeme AG (Germany)
• Medherant Limited (U.K.)
• 코리움, LLC. (미국)
• Bayer AG(독일)
• 노바티스 AG(스위스)
• 안타레스파마(미국)
• 애벗(미국)
• 마일런 NV(미국)
• Acrux Limited(호주)
• Sparsha Pharma International Pvt Ltd(인도)
• Bliss GVS Pharma. (인도)
• 존슨앤존슨 서비스 주식회사(미국)
• Informa Connect Limited(영국)

SKU-28669